118 related articles for article (PubMed ID: 7633830)
1. Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.
Fichtner I; Reszka R; Goan SR; Naundorf H
Med Oncol; 1994; 11(3-4):111-9. PubMed ID: 7633830
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin-liposomes as activators of hematopoiesis.
Fichtner I; Reszka R; Schütt M; Rudolph M; Becker M; Lemm M; Richter J; Berger I
Oncol Res; 1993; 5(2):65-74. PubMed ID: 8364255
[TBL] [Abstract][Full Text] [Related]
3. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
Bally MB; Nayar R; Masin D; Cullis PR; Mayer LD
Cancer Chemother Pharmacol; 1990; 27(1):13-9. PubMed ID: 2245488
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postirradiation hemopoietic effects of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) administered to C57Bl/6 mice before irradiation.
Macková NO; Fedorocko P
Neoplasma; 1993; 40(6):379-85. PubMed ID: 8289971
[TBL] [Abstract][Full Text] [Related]
5. Tumor inhibition and hematopoietic stimulation in mice by a synthetic copper-ATP complex.
Pal S; Ray MR; Maity P
Anticancer Drugs; 1993 Aug; 4(4):505-10. PubMed ID: 8400354
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.
Schwendener RA; Fiebig HH; Berger MR; Berger DP
Cancer Chemother Pharmacol; 1991; 27(6):429-39. PubMed ID: 2013113
[TBL] [Abstract][Full Text] [Related]
7. Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft.
Chaudhury A; Das S; Bunte RM; Chiu GN
Int J Nanomedicine; 2012; 7():739-51. PubMed ID: 22359453
[TBL] [Abstract][Full Text] [Related]
8. Hematologic effects of a single dose of methylnitrosourea.
Seidel HJ
Exp Hematol; 1977 Jan; 5(1):19-26. PubMed ID: 832681
[TBL] [Abstract][Full Text] [Related]
9. Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice.
Treskes M; Boven E; van de Loosdrecht AA; Wijffels JF; Cloos J; Peters GJ; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 1994; 30A(2):183-7. PubMed ID: 8155393
[TBL] [Abstract][Full Text] [Related]
10. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
[TBL] [Abstract][Full Text] [Related]
11. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.
Williams SS; Alosco TR; Mayhew E; Lasic DD; Martin FJ; Bankert RB
Cancer Res; 1993 Sep; 53(17):3964-7. PubMed ID: 8358724
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and differentiation of transplanted bone marrow from mice treated with nitrogen mustard.
Sharp JG; THOMAS DB; Briscoe CV
Exp Hematol; 1974; 2(1):1-8. PubMed ID: 4614984
[No Abstract] [Full Text] [Related]
13. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
14. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
15. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
16. Prolonged effects of nitrogen mustard on mouse haematopoietic and lymphoid tissues.
Sharp JG; Thomas DB; Briscoe CV; Littlewood V
Scand J Haematol; 1975 Jun; 14(5):313-9. PubMed ID: 1215828
[TBL] [Abstract][Full Text] [Related]
17. Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein.
Naundorf H; Zschiesche W; Reszka R; Fichtner I
In Vivo; 1995; 9(3):247-51. PubMed ID: 8562891
[TBL] [Abstract][Full Text] [Related]
18. [Long-term consequences of the damaging effect of cytostatic drugs on hematopoiesis and lymphoid tissue].
Gol'dberg ED; Novitskiĭ VV; Zapuskalova OB; Klimova MIu
Vestn Akad Med Nauk SSSR; 1990; (9):52-7. PubMed ID: 2264389
[TBL] [Abstract][Full Text] [Related]
19. Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma.
Staflin K; Järnum S; Hua J; Honeth G; Kannisto P; Lindvall M
Int J Gynecol Cancer; 2006; 16(4):1557-64. PubMed ID: 16884365
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the growth factor activity of amniotic fluid on cells from hematopoietic and lymphoid organs of different life stages.
Heidari Z; Isobe K; Goto S; Nakashima I; Kiuchi K; Tomoda Y
Microbiol Immunol; 1996; 40(8):583-9. PubMed ID: 8887353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
